New clinical trial chemotherapy BAY 1187982

After being on the BGJ 398 trial, I had a lymph node that shrunk then started to grow so was taken off the trial at MD Anderson. I was on it for 8 cycles and it was a good ride with few side effects. Just time to move on. So, Dr. Javle and the clinical trial team really wants me to try BAY 1187982. It is an FGFR2 antibody-drug conjugate. Since the BGJ 398 trial quit working, this drug will target FGFR patients with tumor progression, neoangiogenesis, and chemo resistance. The antibody drug conjugate carries a microtubule auristatin. It is in phase one but showing great promise so far. I first, before anything, want the MATCH program done so I have that information as a backup plan IF I decide to proceed with this trial. It would require visits to MD Anderson every 3 week for liquid chemo. Coming from Illinois….that’s a toughy but we will march on. There are four sites total doing this trial so I am limited to places closer to home to have the chemo every 3 weeks. Anyone else know much about this drug or anyone on it with any input on how they are doing. I have searched Bayer (drug company) and they had about a page of info but no real people to talk to who are on this trial. They are very highly recommending I consider this trial. I am just looking for any patients on this trial. I searched the CC site here and came up with nothing. Anyone out there with knowledge about this is encouraged to message me or call me at 618-392-2239. Thanks for reading all this jibberish~~
EVERY DAY IS A GOOD DAY!!
Patty in Illinois~